IRIS
SONVICO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.790
EU - Europa 4.442
AS - Asia 2.601
OC - Oceania 20
SA - Sud America 19
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 13
Totale 11.902
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.725
CN - Cina 1.512
IE - Irlanda 1.086
SE - Svezia 813
SG - Singapore 696
IT - Italia 667
FI - Finlandia 653
DE - Germania 376
UA - Ucraina 365
TR - Turchia 230
FR - Francia 180
GB - Regno Unito 76
CA - Canada 61
IN - India 60
AT - Austria 51
NL - Olanda 50
VN - Vietnam 47
CZ - Repubblica Ceca 35
BE - Belgio 31
ES - Italia 19
AU - Australia 15
EU - Europa 13
JP - Giappone 12
CI - Costa d'Avorio 10
HK - Hong Kong 10
BR - Brasile 9
AR - Argentina 7
IL - Israele 6
PT - Portogallo 6
NZ - Nuova Zelanda 5
PK - Pakistan 5
RU - Federazione Russa 5
HU - Ungheria 4
KR - Corea 4
RO - Romania 4
BG - Bulgaria 3
DK - Danimarca 3
IR - Iran 3
MX - Messico 3
PL - Polonia 3
SA - Arabia Saudita 3
TW - Taiwan 3
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
GE - Georgia 2
HR - Croazia 2
LT - Lituania 2
LU - Lussemburgo 2
MY - Malesia 2
RS - Serbia 2
TH - Thailandia 2
BD - Bangladesh 1
BT - Bhutan 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
IQ - Iraq 1
MD - Moldavia 1
NG - Nigeria 1
YE - Yemen 1
ZA - Sudafrica 1
Totale 11.902
Salva come PNG Salva come JPEG
Città #
Dublin 1.072
Chandler 914
Singapore 525
Jacksonville 431
Ashburn 393
Beijing 329
Dearborn 326
Ann Arbor 324
Boardman 261
Parma 227
Nanjing 222
Izmir 184
Princeton 179
Shanghai 156
Wilmington 121
San Mateo 94
Helsinki 83
Bremen 81
Shenyang 74
Nanchang 72
Woodbridge 70
New York 61
Hebei 58
Hefei 57
Seattle 57
Des Moines 55
Kunming 55
Guangzhou 49
Dong Ket 47
Jiaxing 47
Toronto 47
Los Angeles 45
Santa Clara 45
Milan 43
Vienna 43
Jinan 42
Houston 38
Changsha 34
Groningen 33
Fremont 31
Marseille 31
Shenzhen 30
Tianjin 30
Brussels 28
Brno 27
Pune 27
Rome 24
Falls Church 23
Grafing 23
Munich 23
Norwalk 22
Konyaalti 21
Bologna 20
Dallas 19
Zhengzhou 19
Reggio Emilia 18
Chicago 16
Ningbo 16
Kocaeli 13
London 13
Hangzhou 12
Istanbul 11
Abidjan 10
Fairfield 10
Fuzhou 10
Segrate 10
Sydney 10
Brescia 9
Hyderabad 9
Padova 9
Taizhou 9
Wenzhou 9
Amsterdam 8
Ardea 8
Santiago De Compostela 8
Taiyuan 8
Mestre 7
Redwood City 7
Washington 7
Chengdu 6
Frankfurt am Main 6
Haikou 6
Modena 6
Ottawa 6
Paris 6
Stockholm 6
Strasbourg 6
Wuhan 6
Auburn Hills 5
Düsseldorf 5
Edinburgh 5
Montegaldella 5
Naples 5
Verona 5
Xian 5
Auckland 4
Cantù 4
Chongqing 4
Ferrara 4
Macomer 4
Totale 7.748
Salva come PNG Salva come JPEG
Nome #
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model 151
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 143
MULTILAYERED PHARMACEUTICAL FORMULATION 122
Opportunity and challenges of nasal powders: Drug formulation and delivery 121
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 115
Combined hyaluronate-based films loaded with pemetrexed and cisplatin for the treatment of malignant pleural mesothelioma: Preliminary evaluation in an orthotopic tumor recurrence model 112
Mechanisms of formation and disintegration of alginate beads obtained by prilling 105
Chitosan-Coated Nanoparticles: Effect of Chitosan Molecular Weight on Nasal Transmucosal Delivery 105
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 104
Intrapleural polymeric devices containing Cisplatin for malignant pleural Mesothelioma in a rat tumor model: a preliminary study. 102
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 100
Identifying contact-mediated, localized toxic effects of MWCNT aggregates on epithelial monolayers: A single-cell monitoring toxicity assay 99
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 98
Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products 98
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 96
Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma 95
Intrapleural adjuvant treatment of mesothelioma : The combination of cisplatin-pemetrexed in rat tumor model 94
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 92
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 91
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 91
Les formes pharmaceutiques du futur 89
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 89
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 88
A NEW GASTRORETENTIVE DOSAGE FORM: FLOATING DOME MATRIX®. FORMULATION AND IN VITRO RELEASE STUDIES OF RIBOFLAVIN. 86
In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates 86
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 86
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens 86
Dynamics of lipid–saccharide nanoparticles by quasielastic neutron scattering 85
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 84
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 83
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 83
Anti-Inflammatory Properties of Statin-Loaded Biodegradable Lecithin/Chitosan Nanoparticles: A Step Toward Nose-to-Brain Treatment of Neurodegenerative Diseases 83
Assemblage of novel release modules for the development of adaptable drug delivery systems 82
Dynamics of water and small molecules in bioadhesive polymer films 82
IN13 Backscattering Spectrometer at ILL: Looking for Motions in Macromolecules and Organisms 82
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 82
Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate 82
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 81
Flexibility and drug release features of lipid/saccharide nanoparticles 80
Application of quasi-elastic neutron scattering to the investigation of the dynamics and release properties of single-layer transdermal films containing lidocaine 80
Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye 80
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 79
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 79
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 78
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 77
Mean square hydrogen fluctuations in chitosan/lecithin nanoparticles from elastic neutron scattering experiments 77
The effect of residual water on antacid activity of sucralfate gel dried by microwaves 76
Structure of Self-Organized Multilayer Nanoparticles for Drug Delivery 76
Sprayable pharmaceutical compositions comprising sucralfate gel for treating skin or mucosa lesions 76
New modules, new assembly kits and new assembles for controlled release of substances 74
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 74
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 74
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 74
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant 74
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 73
Opportunities and Challenges for the Nasal Administration of Nanoemulsions 73
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 73
Chimeral agglomerates of microparticles for nasal administration of analgesic drug powders 72
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 72
Brain distribution of ribavirin after intranasal administration 72
Crystallization of stable doped mannitol polymorphs and in vitro assessment of their safety as carriers for lung delivery 72
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 71
Assembled modules technology for site-specific prolonged delivery of norfloxacin 69
Le Basi del Calcolo Farmaceutico 69
Ucuùba Fat Characterization and Use to Obtain Lipid Nanoparticles by High-Pressure Homogenization with Full Factorial Design 69
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: the enhancing effect of potassium sorbate 69
Intrapleural application of polymeric films containing cisplatin and pemetrexed in a rat tumour model of malignant pleural mesothelioma 69
Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid 69
Biological In Vitro Models for Absorption by Nonoral Routes 68
Gel-like TPGS-Based Microemulsions for Imiquimod Dermal Delivery: Role of Mesostructure on the Uptake and Distribution into the Skin 68
Biohadesive sucralfate gel based suspension containing cidofovir for spray treatment of viral infections in lamb and sheep 68
Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa 67
Cell penetrating peptides in ocular drug delivery: State of the art 67
Modular systems fitted together for the controlled release of substances 65
High Respirable Insulin Dry Powder for Pulmonary Administration 65
Novel O/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetration 65
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 65
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 64
Dome Matrix® technology : effect of drug solubility on release kinetics of swellable delivery modules 64
The development of amikacin dry powder for pulmonary administration 64
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting 64
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 64
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 63
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 63
Single layer transdermal film containing lidocaine: water and lidocaine mobility determined using neutron scattering 63
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 63
Establishment of an in vitro model expressing the folate receptor for the investigation of targeted delivery systems 62
Water diffusivity in PVA-based transdermal patches 62
A consensus research agenda for optimising nasal drug delivery 62
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 62
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 61
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake 61
Investigation of the swelling behavior of Dome Matrix drug delivery modules by high-resolution X-ray computed tomography 61
Development and validation of a RP-HPLC method for the simultaneous detection and quantification of simvastatin's isoforms and coenzyme Q10 in lecithin/chitosan nanoparticles 61
Nasal Powders of Morphine Microcrystal Agglomerates 61
The role of lipophilic adjuvant to produce high respirable tobramicin powders for inhalation 61
Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin 61
Fluorescent Multifunctional Organic Nanoparticles for Drug Delivery and Bioimaging: A Tutorial Review 60
Nasal delivery as a strategy for the prevention and treatment of COVID-19 60
From tablets to pharmaceutical nanotechnologies: Innovation in drug delivery strategies for the administration of antimalarial drugs 60
Totale 7.898
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.184 0 0 0 0 151 255 262 57 163 154 37 105
2020/20211.085 22 114 93 37 122 60 130 35 218 50 129 75
2021/2022979 24 36 19 66 45 61 98 103 50 71 55 351
2022/20233.549 367 386 220 258 287 361 37 259 1.192 31 107 44
2023/20241.636 86 129 40 62 115 359 222 126 47 100 138 212
2024/20251.229 124 256 330 395 124 0 0 0 0 0 0 0
Totale 12.279